Pitavastatin shows pomise in overcoming chemotherapy resistance in triple-negative br

[News]

Triple-negative breast cancer (TNBC) is among the most aggressive types of breast cancer, lacking estrogen, progesterone, and HER2 receptors and thus relying primarily on cytotoxic chemotherapy.

More... (https://www.news-medical.net/news/20260107/Pitavastatin-shows-pomise-in-overcoming-chemotherapy-resistance-in-triple-negative-breast-cancer.aspx)